Literature DB >> 4621395

Cross-protection studies and search for subclinical disease in new world monkeys infected sequentially with different immunologic types of Dengue viruses.

W F Scherer, F A Breakenridge, R W Dickerman.   

Abstract

Entities:  

Mesh：

Year:  1972        PMID： 4621395     DOI： 10.1093/oxfordjournals.aje.a121372

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  12 in total

1.  Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.

Authors:  Wen-Yang Tsai; Anna Durbin; Jih-Jin Tsai; Szu-Chia Hsieh; Stephen Whitehead; Wei-Kung Wang
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

2.  Homotypic Dengue Virus Reinfections in Nicaraguan Children.

Authors:  Jesse J Waggoner; Angel Balmaseda; Lionel Gresh; Malaya K Sahoo; Magelda Montoya; Chunling Wang; Janaki Abeynayake; Guillermina Kuan; Benjamin A Pinsky; Eva Harris
Journal:  J Infect Dis       Date:  2016-03-16       Impact factor: 5.226

3.  Chemically induced temperature-sensitive mutants of dengue virus type 2: comparison of temperature sensitivity in vitro with infectivity suckling mice, hamsters, and rhesus monkeys.

Authors:  G C Tarr; A S Lubiniecki
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

4.  Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model.

Authors:  Jennifer L Kyle; Scott J Balsitis; Luhua Zhang; P Robert Beatty; Eva Harris
Journal:  Virology       Date:  2008-09-06       Impact factor: 3.616

5.  Models of dengue virus infection.

Authors:  Dennis A Bente; Rebeca Rico-Hesse
Journal:  Drug Discov Today Dis Models       Date:  2006

6.  Immunocompetent mice model for dengue virus infection [corrected].

Authors:  Denise Gonçalves; Rafael de Queiroz Prado; Eric Almeida Xavier; Natália Cristina de Oliveira; Paulo Marcos da Matta Guedes; João Santana da Silva; Luiz Tadeu Moraes Figueiredo; Victor Hugo Aquino
Journal:  ScientificWorldJournal       Date:  2012-05-15

7.  Sequential dengue virus infections detected in active and passive surveillance programs in Thailand, 1994-2010.

Authors:  Piraya Bhoomiboonchoo; Ananda Nisalak; Natkamol Chansatiporn; In-Kyu Yoon; Siripen Kalayanarooj; Mathuros Thipayamongkolgul; Timothy Endy; Alan L Rothman; Sharone Green; Anon Srikiatkhachorn; Darunee Buddhari; Mammen P Mammen; Robert V Gibbons
Journal:  BMC Public Health       Date:  2015-03-14       Impact factor: 3.295

8.  High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection.

Authors:  Wen-Yang Tsai; Chih-Yun Lai; Yi-Chieh Wu; Hong-En Lin; Carolyn Edwards; Amonrat Jumnainsong; Srisakul Kliks; Scott Halstead; Juthathip Mongkolsapaya; Gavin R Screaton; Wei-Kung Wang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

Review 9.  Can non-human primates serve as models for investigating dengue disease pathogenesis?

Authors:  Kristina B Clark; Nattawat Onlamoon; Hui-Mien Hsiao; Guey C Perng; Francois Villinger
Journal:  Front Microbiol       Date:  2013-10-11       Impact factor: 5.640

10.  Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases.

Authors:  Chih-Yun Lai; Katherine L Williams; Yi-Chieh Wu; Sarah Knight; Angel Balmaseda; Eva Harris; Wei-Kung Wang
Journal:  PLoS Negl Trop Dis       Date:  2013-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.